APA (7th ed.) Citation

Chen, X., Chang, Z., & Liu, Z. (2019). d-dimer increase: An unfavorable factor for patients with primary liver cancer treated with TACE. Cancer chemotherapy and pharmacology, 83(4), 797-802. https://doi.org/10.1007/s00280-019-03778-6

Chicago Style (17th ed.) Citation

Chen, Xujiao, Zhihui Chang, and Zhaoyu Liu. "D-dimer Increase: An Unfavorable Factor for Patients with Primary Liver Cancer Treated with TACE." Cancer Chemotherapy and Pharmacology 83, no. 4 (2019): 797-802. https://doi.org/10.1007/s00280-019-03778-6.

MLA (9th ed.) Citation

Chen, Xujiao, et al. "D-dimer Increase: An Unfavorable Factor for Patients with Primary Liver Cancer Treated with TACE." Cancer Chemotherapy and Pharmacology, vol. 83, no. 4, 2019, pp. 797-802, https://doi.org/10.1007/s00280-019-03778-6.